NICE

Several commonly used treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE says in new draft guidance

Rezum recommended as a treatment option for moderate to severe lower urinary tract symptoms.

The Commission on Human Medicines has said patients can take paracetamol or ibuprofen when self-medicating for symptoms of Covid-19.

Fremanezumab now available on the NHS in England and Wales for up to 10,000 people.

Digital tools should be offered in addition to existing health services, not as a replacement, says NICE

NICE is calling for the NHS to make greater use of community pharmacies to promote health and wellbeing in local areas.

Doctors can prescribe Epidyolex with clobazam, a seizure-preventing cannabis-based treatment.

European authorities have for the first time approved a cannabis-based medicine for use in severe childhood epilepsy.

The new recommendations reduce the CVD risk threshold at which treatment for hypertension should be considered.

NICE has decided not to recommend the use of cannabis-based medicines in severe treatment-resistant epilepsy.

e number of people suffering with the tick-borne infection may be about three times higher than the official estimate.

Pharmacists in all settings should be integrated into services aimed at preventing and managing type 2 diabetes.

When working within a care home, do you understand the CQC inspection process? Hilary Cunningham, information pharmacist at Numark, explains how you can get it right.

The National Institute for Health and Care Excellence (NICE) has published Quality Standard (QS171) on medicines management for people receiving social care in the community.  

Healthcare professionals should consider the risk of antimicrobial resistance when deciding whether antibiotics are needed for treating or preventing a flare up of symptoms of chronic obstructive pulmonary disease (COPD).

Guidance to help spot Lyme disease more quickly has been issued by NICE. The guideline lists symptoms to look out for, tests to help confirm a diagnosis and what treatments to use.

NICE has recognised three clinical programmes delivered by Leeds-based Interface Clinical Services.

People with suspected late AMD (wet active) should be referred to a macula service within one working day, says NICE in newly published guidance

Finlay Hesketh is a young boy with Duchenne muscular dystrophy (DMD), a cruel muscle-wasting illness that has few treatment options and which sees sufferers becoming wheelchair dependent by the age of 12. Later, they will need artificial ventilation to help them breathe and death usually follows before the age of 30. It’s horrific. A new treatment is available – ataluren – which has been described by NICE as a “step change” in care that can delay the loss of the ability to walk for up to seven years, offering children the chance of a normal adolescence and allowing them to stay in school for much longer.

News in brief: Use of NSAIDs in children with chickenpox